• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.13% Nasdaq Up 0.70%

    RXi Pharmaceuticals Corporation (RXII)

    -NasdaqCM
    1.60 Dec 26, 3:59PM EST
    Add to Portfolio
    Prev Close:1.60
    Open:1.60
    Bid:1.24 x 100
    Ask:2.50 x 100
    1y Target Est:10.17
    Beta:1.97
    Next Earnings Date:N/A
    Day's Range:1.59 - 1.62
    52wk Range:1.40 - 6.84
    Volume:159,161
    Avg Vol (3m):206,241
    Market Cap:33.81M
    P/E (ttm):N/A
    EPS (ttm):-0.99
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for RXII

    Comparison

    Symbol% ChgMkt Cap
    RXII 0.00%33.81M
    AGN63.14B
    ALNY7.53B
    MRNA17.25M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):393.15
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.90
    Quarterly EPS Est (Dec-14) :-0.19
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    RXi Pharmaceuticals Corporation, a biotechnology company, focuses on discovering, developing, and commercializing therapies based on its proprietary, next-generation RNA interference (RNAi) platform. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback